Abstract:Background and objective: Boronated porphyrins have emerged as promising dual sensitizers for use in both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT), by virtue of their known tumor affinity, low cytotoxicity in dark conditions, and easy synthesis with high boron content. Octa-anionic 5,10,15,20-tetra[3,5-(nido-carboranylmethyl)phenyl] porphyrin (H₂OCP) is a boronated porphyrin having eight boron clusters linked to the porphyrin ring. To evaluate H₂OCP's applicability to both PDT and BNCT, we performed an in vitro and ex vivo study using F98 rat glioma cells. Materials and methods: We examined the time-dependent cellular uptake of H₂OCP by measuring the boron concentration over time, and compared the cellular uptake/clearance of boron after exposure to H₂OCP in conjunction with boronophenylalanine (BPA) and sodium borocaptate (BSH), both of which are currently used in clinical BNCT studies. We evaluated the cytotoxicity of H₂OCP-mediated PDT using a colony-forming assay and assessed the tumorigenicity of the implantation of pre-treated cells using Kaplan-Meier survival curves. Fluorescence microscopy was also performed to evaluate the cellular uptake of H₂OCP. Results: H₂OCP accumulated within cells to a greater extent than BPA/BSH, and H₂OCP was retained inside the cells to approximately the same extent as BSH. The cell-surviving fraction following laser irradiation (8 J/cm², 18 hours after exposure to 10 µg B/ml H₂OCP) was <0.05. The median survival times of the pre-treated cell-implanted rats were longer than those of the untreated group (P < 0.05). The fluorescence of H₂OCP was clearly demonstrated within the tumor cells by fluorescence microscopy. Conclusions: H₂OCP has been proven to be a promising photosensitizer for PDT. H₂OCP has also been proposed as a potentially effective replacement of BPA or BSH, or as a replacement of both BPA/BSH. Our study provides more evidence that H₂OCP could be an effective novel dual sensitizing agent for use in both PDT and BNCT.

A H2o2-Responsive Boron Dipyrromethene-Based Photosensitizer For Imaging-Guided Photodynamic Therapy

A simple hydrogen peroxide-activatable Bodipy for tumor imaging and type I/II photodynamic therapy

H2O2-activated mitochondria-targeting photosensitizer for fluorescence imaging-guided combination photodynamic and radiotherapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Photosensitizer Synergistic Effects: D-A-D Structured Organic Molecule with Enhanced Fluorescence and Singlet Oxygen Quantum Yield for Photodynamic Therapy.

H2O2-responsive Biodegradable Nanomedicine for Cancer-Selective Dual-Modal Imaging Guided Precise Photodynamic Therapy

pH-Sensitive and Lysosome Targetable Photosensitizers Based on BODIPYs

2-Pyridone-functionalized Aza-BODIPY Photosensitizer for Imaging-Guided Sustainable Phototherapy

Molecular Design of Monochromophore-Based Bifunctional Photosensitizers for Simultaneous Ratiometric Oxygen Reporting and Photodynamic Cancer Therapy

Mitochondria-Targeting Boron Dipyrromethene Based Photosensitizers for Enhanced Photodynamic Therapy: Synthesis, Optical Properties, and in Vitro Biological Activity.

Trifluoromethyl Boron Dipyrromethene Derivatives As Potential Photosensitizers For Photodynamic Therapy

Application of a novel boronated porphyrin (H₂OCP) as a dual sensitizer for both PDT and BNCT

BODIPY-doped Silica Nanoparticles with Reduced Dye Leakage and Enhanced Singlet Oxygen Generation.

Boron Dipyrromethene-Based Phototheranostics for Near Infrared Fluorescent and Photoacoustic Imaging-Guided Synchronous Photodynamic and Photothermal Therapy of Cancer

Insights into the Binding Mechanism of BODIPY-based Photosensitizers to Human Serum Albumin: A Combined Experimental and Computational Study.

Tumor activated water-soluble photosensitizers for near-infrared photodynamic cancer therapy.

Hydrogen Peroxide-Activatable Iodobodipy-Phthalhydrazid Conjugate Nanoparticles for Cancer Therapy

The orthogonal α‐meso‐Linked bisBODIPY photosensitizers demonstrate effective two‐photon fluorescence imaging and photodynamic therapy

BODIPY-based macromolecular photosensitizer with selective recognition and enhanced anticancer efficiency

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in Vitro and in Vivo Evaluation for Photodynamic Therapy

A Near-Infrared and Lysosome-Targeted Coumarin-Bodipy Photosensitizer for Photodynamic Therapy Against HepG2 Cells